The researchers in the Clinical Psychopharmacology Unit (CPU) aim to understand the intersection between drugs and the brain and mind, in order to develop the next-generation of treatments to improve mental health.
We are a multidisciplinary lab, incorporating psychologists, neuroscientists and clinicians and our research spans basic psychological science to world-first clinical trials.